BDR Pharmaceuticals is an Indian pharmaceutical company founded by Dharmesh Shah in 2003, specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished formulations, particularly for oncology, critical care, gynecology, and neurology. Driven by a mission to provide affordable and accessible healthcare, BDR focuses on identifying niche molecules and creating first-to-market generic alternatives for life-threatening diseases to address therapeutic gaps. The company operates with both a domestic and international presence, with a growing focus on expanding its global footprint, including a planned expansion into the U.S. market.